FluidAI Medical Announces $15M in Series A Funding for AI-Driven Postoperative Monitor at HLTH 2023
Summary
They not only jeopardize the health and recovery of the patient but also place additional burdens on the healthcare system, including prolonged hospital stays and increased medical expenses. FluidAIs timely funding underscores the industrys pressing need for innovative solutions that can ensure patient safety, reduce hospital stays, and ultimately cut down healthcare costs. Together, we are committed to a healthier, brighter future for all," said Nabil Borhanu, Founder & Managing Partner, Graphene Ventures The investment will allow FluidAI to expand into existing and new global markets, grow its dynamic team, amplify R&D efforts, and introduce novel AI-driven solutions catering to a broader range of postoperative complications. From general to gastrointestinal surgeries, FluidAIs mission is to empower healthcare providers with data-driven solutions that improve patient outcomes and advance postoperative care. With offices in Palo Alto, Toronto, S\xe3o Paulo, and Riyadh, the firm has a global reach and is dedicated to helping its portfolio companies scale into multiple markets.